We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+9.76%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.3B
AUM Growth
+$92.1M
(+7.6%)
Cap. Flow
+$25M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
36.27%
Holding
543
New
63
Increased
193
Reduced
214
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Gold
UGL
|
+$16.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$6.26M |
| 3 |
Micron Technology
MU
|
+$4.07M |
| 4 |
Meta Platforms (Facebook)
META
|
+$3.94M |
| 5 |
Ferrari
RACE
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$11.5M |
| 2 |
iShares Silver Trust
SLV
|
+$7.75M |
| 3 |
Amazon
AMZN
|
+$6.78M |
| 4 |
Oracle
ORCL
|
+$2.75M |
| 5 |
Royal Caribbean
RCL
|
+$2.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.86% |
| 2 | Healthcare | 22.63% |
| 3 | Communication Services | 13.04% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Consumer Staples | 2.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Enanta Pharmaceuticals
ENTA
$393M
| $74.2K | 0.01% |
4,703
-4,044
| -46% | -$51.4K |
|
427
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $74.1K | 0.01% |
608
-4,311
| -88% | -$494K |
|
428
Eton Pharmaceutcials
ETON
$1.14B
| $73.9K | 0.01% |
+4,370
| New | +$76.9K |
|
429
PepGen
PEPG
$201M
| $72.9K | 0.01% |
11,202
+5,453
| +95% | +$28.3K |
|
430
Solid Biosciences
SLDB
$971M
| $71.6K | 0.01% |
12,695
-954
| -7% | -$5.17K |
|
431
SIGA Technologies
SIGA
$206M
| $71.3K | 0.01% |
11,669
-882
| -7% | -$6.27K |
|
432
China Yuchai International
CYD
$1.76B
| $71K | 0.01% |
2,000
| – | – |
|
433
Evolus
EOLS
$536M
| $70.2K | 0.01% |
10,562
-776
| -7% | -$5.26K |
|
434
4D Molecular Therapeutics
FDMT
$621M
| $69.8K | 0.01% |
9,310
+1,124
| +14% | +$11.4K |
|
|
NBP
435
NovaBridge Biosciences American Depositary Shares
NBP
$216M
| $67.4K | 0.01% |
+16,940
| New | +$75K |
|
436
Kyverna Therapeutics
KYTX
$489M
| $67.1K | 0.01% |
7,137
-443
| -6% | -$3.29K |
|
437
Kamada
KMDA
$397M
| $66.4K | 0.01% |
+9,399
| New | +$65K |
|
|
AUTL
438
Autolus Therapeutics
AUTL
$564M
| $65K | 0.01% |
32,687
-2,470
| -7% | -$3.79K |
|
439
Entrada Therapeutics
TRDA
$299M
| $64K | ﹤0.01% |
6,228
-439
| -7% | -$3.7K |
|
440
Rocket Pharmaceuticals
RCKT
$374M
| $61.9K | ﹤0.01% |
17,635
-1,279
| -7% | -$4.38K |
|
441
Altimmune
ALT
$570M
| $61.4K | ﹤0.01% |
17,003
+1,533
| +10% | +$6.68K |
|
442
CAMP4 Therapeutics
CAMP
$284M
| $61.3K | ﹤0.01% |
+10,000
| New | +$42.5K |
|
443
Aura Biosciences
AURA
$802M
| $56.4K | ﹤0.01% |
10,348
-541
| -5% | -$3.21K |
|
|
BCYC
444
Bicycle Therapeutics
BCYC
$284M
| $53.4K | ﹤0.01% |
7,540
-564
| -7% | -$4.16K |
|
445
Aclaris Therapeutics
ACRS
$860M
| $53.1K | ﹤0.01% |
+17,655
| New | +$44.6K |
|
446
Larimar Therapeutics
LRMR
$454M
| $53.1K | ﹤0.01% |
13,947
-1,056
| -7% | -$4.11K |
|
447
Neurogene
NGNE
$738M
| $52K | ﹤0.01% |
2,524
+22
| +0.9% | +$548 |
|
448
Anavex Life Sciences
AVXL
$316M
| $51.8K | ﹤0.01% |
14,559
-497
| -3% | -$3.04K |
|
449
AC Immune
ACIU
$267M
| $51.4K | ﹤0.01% |
16,362
-1,238
| -7% | -$3.9K |
|
450
Candel Therapeutics
CADL
$783M
| $50.5K | ﹤0.01% |
+8,946
| New | +$48.1K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q4 2025 Portfolio in Review
As of Q4 2025, China Universal Asset Management Company held 543 positions worth $1.3B, up 7.6% from $1.21B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
China Universal Asset Management Company's Q4 2025 filing shows 63 new, 193 increased, 214 reduced and 47 closed positions. Its largest new stake was Western Digital: 13,175 shares worth $2.27M. The largest sale was Broadcom, an estimated $11.5M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 40% a quarter earlier, followed by Healthcare and Communication Services.
- China Universal Asset Management Company's largest Q4 2025 buy was Western Digital: 13,175 shares worth $2.27M.
- China Universal Asset Management Company added most to ProShares Ultra Gold in Q4 2025, an estimated $16.2M increase.
- China Universal Asset Management Company's biggest Q4 2025 reduction was Broadcom, cutting an estimated $11.5M.
- China Universal Asset Management Company fully exited Royal Caribbean in Q4 2025, selling an estimated $2.72M.
- China Universal Asset Management Company's ten largest holdings make up 36% of its $1.3B portfolio in Q4 2025.
- China Universal Asset Management Company opened 63 new positions and closed 47 in Q4 2025.
- China Universal Asset Management Company's portfolio value rose 7.6% quarter-over-quarter to $1.3B.
Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.